Fritextsökning
Innehållstyper
-
TV: Astrazeneca väljer Sverige
Och vill se fler life science-grannar i Göteborg
-
Nano-antikropp från alpacka blockerade coronavirus
Ett fragment av en antikropp från en alpacka verkar kunna blockera det nya corona-viruset från att ta sig in i celler.
-
Studie: Barn har oftare antikroppar som korsreagerar med coronaviruset
Enligt en ny studie förekommer det ibland antikroppar hos personer som inte haft covid-19 som korsreagerar med det nya coronaviruset sars-cov-2.
-
Specialröntgen möjlig i Göteborg
På Sahlgrenska finns nu en så kallad EOS – röntgenutrustning som får in en hel stående person på en enda bild. Detta efter anslag från Lundbergs forskningsstiftelse.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Double the channels for half the work
The 16-well pipettes from Capp cause less strain for the user when setting up a 384-well plate.
-
Abbvie i topp för bästa arbetsplatserna 2020
Läkemedelsföretaget Abbvie rankas som femte mest trivsamma arbetsplatsen i rankningen Sveriges bästa arbetsplatser.
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...
-
New automated solution for flexible molecular assays
The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.
-
Measurement of calorific content in a matter of minutes
The AC600 calorimeter from Leco uses rapid thermodynamics to analyze calorific content in five minutes.
-
Showroom for free
The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...
-
Bakom de gröna ambitionerna
Många läkemedelsföretag inkluderar i dag ett miljötänk i tillverkningen av läkemedel. Men få är villiga att redovisa faktiska siffror i Life Science Swedens enk...
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
Higher performance UV-Vis spectrophotometry with double beams
The Biochrom Libra series of UV-Vis spectrophotometers now features double beams and variable bandwidths.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
View pathology images in your iPhone
The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
They’re all doing it – buying drug research
It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Glöm inte den 12 december!
Tredje gången gillt för Pharma Outsourcing, en dag för Sveriges växande, läkemedelsutvecklande företag. En dag för nätverkande och möten.
-
Cancer cells cheat suicide call
Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of...
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.